These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4136451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M, Mizuno S, Murata H, Oshima T.
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H, Yamadori H, Inoue N, Mabuchi H, Ikeda N, Maekawa N.
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract] [Full Text] [Related]

  • 6. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
    Fukuhara Y.
    Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M, Mizuno S.
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [Abstract] [Full Text] [Related]

  • 9. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K.
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract] [Full Text] [Related]

  • 10. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK, Kanes W, Davidson PT, Moulding TS.
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
    Tsukamura M.
    Microbiol Immunol; 1980 Mar; 24(1):11-9. PubMed ID: 6153747
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
    Shimizu T.
    Jpn J Antibiot; 1974 Dec; 27(6):766-74. PubMed ID: 4142798
    [No Abstract] [Full Text] [Related]

  • 17. [Isolation of kanamycin or viomycin-resistant M. tuberculosis from tuberculous patients].
    Endo K, Takahashi M, Hashimoto H, Mitsuhashi S.
    J Antibiot B; 1967 Feb; 20(1):1-5. PubMed ID: 4292905
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The antimycobacterial activity of capreomycin.
    Lucchesi M.
    Antibiot Chemother; 1970 Feb; 16():27-31. PubMed ID: 4108891
    [No Abstract] [Full Text] [Related]

  • 20. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M, Toyama H, Mizuno S, Tsukamura S.
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.